LBPH logo

Longboard Pharmaceuticals (LBPH) Cash From Operations

Annual CFO

-$50.87 M
-$12.80 M-33.64%

31 December 2023

LBPH Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

-$20.59 M
-$1.46 M-7.65%

30 September 2024

LBPH Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

-$65.93 M
-$7.31 M-12.46%

30 September 2024

LBPH TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LBPH Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.6%-55.0%-33.2%
3 y3 years-1377.9%-235.8%-221.8%
5 y5 years---

LBPH Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1377.9%at low-262.9%at low-221.8%at low
5 y5 years-1377.9%at low<-9999.0%at low<-9999.0%at low
alltimeall time-1377.9%at low<-9999.0%at low<-9999.0%at low

Longboard Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$20.59 M(+7.7%)
-$65.93 M(+12.5%)
June 2024
-
-$19.13 M(+26.1%)
-$58.63 M(+10.7%)
Mar 2024
-
-$15.18 M(+37.6%)
-$52.95 M(+4.1%)
Dec 2023
-$50.87 M(+33.6%)
-$11.03 M(-17.0%)
-$50.87 M(+2.7%)
Sept 2023
-
-$13.29 M(-1.2%)
-$49.51 M(+7.5%)
June 2023
-
-$13.45 M(+2.7%)
-$46.08 M(+12.0%)
Mar 2023
-
-$13.10 M(+35.4%)
-$41.13 M(+8.1%)
Dec 2022
-$38.06 M
-$9.67 M(-1.8%)
-$38.06 M(+11.7%)
Sept 2022
-
-$9.85 M(+15.7%)
-$34.07 M(+12.3%)
DateAnnualQuarterlyTTM
June 2022
-
-$8.51 M(-15.1%)
-$30.35 M(+12.5%)
Mar 2022
-
-$10.03 M(+76.7%)
-$26.98 M(+9.2%)
Dec 2021
-$24.70 M(+617.8%)
-$5.67 M(-7.5%)
-$24.70 M(+20.6%)
Sept 2021
-
-$6.13 M(+19.1%)
-$20.49 M(+33.1%)
June 2021
-
-$5.15 M(-33.5%)
-$15.40 M(+38.1%)
Mar 2021
-
-$7.75 M(+430.9%)
-$11.15 M(+223.9%)
Dec 2020
-$3.44 M
-$1.46 M(+40.2%)
-$3.44 M(+73.6%)
Sept 2020
-
-$1.04 M(+15.3%)
-$1.98 M(+110.5%)
June 2020
-
-$903.00 K(+2215.4%)
-$942.00 K(+2315.4%)
Mar 2020
-
-$39.00 K
-$39.00 K

FAQ

  • What is Longboard Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Longboard Pharmaceuticals?
  • What is Longboard Pharmaceuticals annual CFO year-on-year change?
  • What is Longboard Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Longboard Pharmaceuticals?
  • What is Longboard Pharmaceuticals quarterly CFO year-on-year change?
  • What is Longboard Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Longboard Pharmaceuticals?
  • What is Longboard Pharmaceuticals TTM CFO year-on-year change?

What is Longboard Pharmaceuticals annual cash flow from operations?

The current annual CFO of LBPH is -$50.87 M

What is the all time high annual CFO for Longboard Pharmaceuticals?

Longboard Pharmaceuticals all-time high annual cash flow from operations is -$3.44 M

What is Longboard Pharmaceuticals annual CFO year-on-year change?

Over the past year, LBPH annual cash flow from operations has changed by -$12.80 M (-33.64%)

What is Longboard Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of LBPH is -$20.59 M

What is the all time high quarterly CFO for Longboard Pharmaceuticals?

Longboard Pharmaceuticals all-time high quarterly cash flow from operations is -$39.00 K

What is Longboard Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, LBPH quarterly cash flow from operations has changed by -$7.31 M (-54.98%)

What is Longboard Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of LBPH is -$65.93 M

What is the all time high TTM CFO for Longboard Pharmaceuticals?

Longboard Pharmaceuticals all-time high TTM cash flow from operations is -$39.00 K

What is Longboard Pharmaceuticals TTM CFO year-on-year change?

Over the past year, LBPH TTM cash flow from operations has changed by -$16.42 M (-33.16%)